CD274 and non-small cell lung carcinoma: The findings from the PEMBROREAL study confirm that pembrolizumab, when used in combination with pemetrexed and platinum salts, is effective and safe in treating metastatic non-squamous NSCLC in patients with PD-L1 < 50%.